Home >> Information & Communications Technology >> Plasma Fractionation Technology Market

Global Plasma Fractionation Technology Market Size,Trends, Growth Forecast to 2031

Category : Information & Communications Technology | Report Code : 1452 | Pages : 141 | Oct 2024

Report Overview

Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called Plasma Fractionation Technology. In this report, we mainly study the Plasma Fractionation Technology products, such as: Immune Globulin, Coagulation Factor, Albumin, etc.

The global Plasma Fractionation Technology market size is projected to grow from US$ 34560 million in 2024 to US$ 54170 million in 2030; it is expected to grow at a CAGR of 7.8% from 2024 to 2030.

Analytic Insights Hub' newest research report, the “Plasma Fractionation Technology Industry Forecast” looks at past sales and reviews total world Plasma Fractionation Technology sales in 2022, providing a comprehensive analysis by region and market sector of projected Plasma Fractionation Technology sales for 2023 through 2029. With Plasma Fractionation Technology sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Plasma Fractionation Technology industry.

This Insight Report provides a comprehensive analysis of the global Plasma Fractionation Technology landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Plasma Fractionation Technology portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Plasma Fractionation Technology market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Plasma Fractionation Technology and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Plasma Fractionation Technology.

Market Drivers:
Increasing Demand for Plasma-Derived Therapies: The rising prevalence of chronic diseases, such as immune deficiencies, hemophilia, and autoimmune disorders, has led to increased demand for plasma-derived products like immunoglobulins, clotting factors, and albumin, driving the Plasma Fractionation Technology market.

Aging Population: The global aging population is more prone to chronic diseases and conditions requiring plasma-derived therapies, contributing to the growth of the Plasma Fractionation Technologyation market.

Growing Use of Immunoglobulins: Immunoglobulins are increasingly used in the treatment of a wide range of diseases, including primary and secondary immune deficiencies, boosting the need for Plasma Fractionation Technology to produce these therapies.

Rising Healthcare Expenditure and Improved Healthcare Access: Expanding healthcare infrastructure in developing countries, combined with rising healthcare expenditure, is driving demand for advanced medical treatments and plasma-derived products.

Market Challenges:
High Costs of Plasma-Derived Products: The complex and time-consuming process of Plasma Fractionation Technologyation leads to high costs for plasma-derived products, making these treatments less accessible, particularly in low-income regions.

Limited Plasma Supply: The availability of plasma for fractionation is often limited by low donation rates, regulatory restrictions, and the lengthy process of screening and collecting plasma, leading to supply shortages.

Stringent Regulatory Framework: Plasma Fractionation Technologyation is subject to rigorous regulatory requirements to ensure safety and efficacy. Meeting these regulations can increase development costs and slow the introduction of new products to the market.

Complex Manufacturing Process: The Plasma Fractionation Technologyation process is technically challenging and requires significant investment in infrastructure, equipment, and skilled labor, posing barriers for new entrants and smaller manufacturers. 
The outbreak of COVID-19 pandemic has led to decrease in number of blood donations and plasma collections, which hampers the market growth as it leads to shortage in raw material supply. 
The classification of Plasma Fractionation Technology includes Immune Globulin, Coagulation Factor, Albumin and Other. In 2023, Immune Globulin accounted for a share of 51% in the global Plasma Fractionation Technology market.

North America is the largest consumption place, with a revenue market share nearly 40 % in 2023. Following North America, Europe is the second largest consumption place with the revenue market share of 24 %; China is also an important sales region for the Plasma Fractionation Technology.

This report presents a comprehensive overview, market shares, and growth opportunities of Plasma Fractionation Technology market by product type, application, key players and key regions and countries.

Segmentation by Type:
    Immune Globulin
    Coagulation Factor
    Albumin
    Other

Segmentation by Application:
    Hospital
    Retail Pharmacy
    Other

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

Segmentation by Type:
    Immune Globulin
    Coagulation Factor
    Albumin
    Other

Segmentation by Application:
    Hospital
    Retail Pharmacy
    Other

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
    Takeda
    CSL
    Grifols
    Octapharma
    Kedrion
    LFB Group
    Biotest
    BPL
    RAAS
    CBPO
    Hualan Bio
    Tiantan Bio
    Shuanglin Bio
    Boya Bio
    Yuanda Shuyang
    Weiguang Bio
    Nanyue Bio
    KM Biologics

Frequently Asked Questions?

Ans - The purpose of a Plasma Fractionation Technology market research report is to provide data-driven insights and analysis on a Plasma Fractionation Technology market. It helps businesses understand industry trends, competition, consumer behavior, market size, growth potential, and risks, supporting strategic decision-making.

Ans - Market research reports typically include both quantitative (market size, revenue, growth rates) and qualitative (trends, consumer preferences, competitive analysis) data. It often includes industry statistics, surveys, expert opinions, historical data, and future forecasts.

Ans - The forecast period typically for Plasma Fractionation Technology market report spans the next 5 to 10 years. It includes projected market trends, growth opportunities, and potential challenges.

Ans - Yes, Analytic Insights Hub customization services, allowing businesses to focus on specific geographies, sectors, or market segments that are relevant to them.

Ans - The report highlights major trends such as technological innovations, consumer behavior shifts, regulatory changes, or emerging markets that may impact the industry?s growth.